WHO PQ Audit Readiness Strategy for US Manufacturers in 2025



WHO PQ Audit Readiness Strategy for US Manufacturers in 2023

Published on 20/12/2025

WHO PQ Audit Readiness Strategy for US Manufacturers in 2023

As the pharmaceutical landscape continues to evolve in response to increasing global demands for high-quality medicines, manufacturers in the United States must align their practices with international standards, particularly the WHO’s prequalification (PQ) program. Achieving WHO prequalification consulting is not merely a regulatory requirement; it represents a commitment to quality that opens doors to broader global supply chains. This article provides a comprehensive, step-by-step guide for US manufacturers on preparing for WHO PQ audits and ensuring inspection readiness in 2023.

Understanding WHO Prequalification (PQ)

The WHO PQ program facilitates access to essential medicines by ensuring quality, safety, and efficacy. The program is especially relevant for manufacturers looking to supply to low- and middle-income countries. Understanding the scope and requirements of PQ audits is critical for compliance and successful market access.

The WHO prequalification system assesses the quality of medicines and vaccines against stringent criteria, aligning with international safety guidelines. To participate, manufacturers must prepare their facilities and products for rigorous evaluation,

which often includes comprehensive inspections and document reviews. Detailed record-keeping and strict adherence to Good Manufacturing Practices (GMP) are crucial aspects of this process.

Step 1: Developing an Audit Readiness Framework

Creating an audit readiness framework is essential for facilitating WHO PQ audits. This framework will serve as a roadmap for your organization’s compliance effort.

  • Establish an Audit Team: Form a dedicated team responsible for audit preparation. This team should include representatives from quality assurance, regulatory affairs, and operations to ensure a multi-disciplinary approach.
  • Conduct a Gap Analysis: Perform a comprehensive assessment to identify areas where your current practices may fall short of WHO PQ requirements. This analysis should include a review of existing quality system documentation, SOPs, and training records.
  • Develop Action Plans: For each identified gap, develop a clear action plan detailing how to address these deficiencies. Assign responsibilities and set deadlines to ensure accountability.
Also Read:  WHO GMP vs FDA 21 CFR 210/211: Practical Compliance Mapping for US Sites

Step 2: Ensuring Compliance with WHO Guidelines

Adherence to WHO guidelines and the applicable regulatory framework, such as ICH-GCP, is imperative in preparing for a PQ audit. Key areas to focus on include:

  • Good Manufacturing Practices (GMP): Ensure that all manufacturing processes comply with international GMP standards. This includes validating processes, performing regular audits, and maintaining documentation.
  • Quality Management Systems: Implement a robust quality management system that encompasses all aspects of production, from sourcing raw materials to product release. Regularly review and update quality policies and SOPs.
  • Documentation Practices: Ensure that all necessary documents, including batch records, testing results, and quality control procedures, are meticulously maintained and easily accessible.

Step 3: Training and Awareness Programs

Personnel training is critical to ensure that your team is well-prepared for the WHO PQ audit. This can be achieved through structured training programs:

  • Foundation Training: Cover the basics of WHO guidelines and the importance of prequalification. This training should be mandatory for all employees involved in manufacturing and quality assurance.
  • Refresher Courses: Conduct regular refresher courses to keep staff updated on any changes in regulations or best practices relevant to WHO PQ audits.
  • Role-Specific Training: Tailor training sessions for specific roles within your organization, such as production staff, quality assurance personnel, and management, emphasizing their respective responsibilities within the PQ process.

Step 4: Mock Audits and Self-Inspections

Conducting mock audits and self-inspections is a practice that can significantly enhance audit readiness:

  • Plan Mock Audits: Schedule regular mock audits mimicking the format and rigor of a WHO PQ audit. This will help familiarize your team with the audit process and identify potential areas of concern.
  • Provide Feedback: After mock audits, provide constructive feedback to the team. Use the information gathered to make necessary adjustments and improvements.
  • Document Findings: Create a comprehensive report summarizing findings from mock audits and self-inspections, outlining action items to address any deficiencies identified.
Also Read:  Global Regulatory Agencies and Guidelines: A Comprehensive Guide for Pharma Professionals

Step 5: Engaging with WHO Prequalification Consulting Services

Consider engaging with experts specializing in WHO prequalification consulting. These professionals can provide invaluable support and guidance throughout the preparation process. They can assist with:

  • Understanding Requirements: Help translate the complex terminology and requirements of WHO guidelines into actionable compliance strategies.
  • Audit Readiness Planning: Collaborate with your organization to develop a tailored audit readiness plan that aligns with your specific manufacturing practices and the products being evaluated.
  • Ongoing Support: Provide ongoing support throughout the audit process, including pre-audit reviews and post-audit follow-ups to ensure continuous compliance and improvements.

Step 6: Continuous Monitoring and Improvement

Post-audit practices are equally important as pre-audit preparations. Continuous monitoring and improvement initiatives should include:

  • Track Key Performance Indicators (KPIs): Establish KPIs related to manufacturing processes, quality assurance outcomes, and compliance metrics.
  • Regular Reviews: Conduct regular reviews of your compliance status, focusing on areas highlighted during the PQ audit. Make changes as necessary to ensure ongoing alignment with WHO standards.
  • Foster a Quality Culture: Encourage a culture of quality within your organization where every employee understands their role in maintaining regulatory compliance.

Step 7: Maintaining Effective Communication with Stakeholders

Effective communication with internal and external stakeholders is crucial for successful WHO PQ audit preparations. Steps to enhance communication include:

  • Internal Communication: Maintain open lines of communication between departments, ensuring that quality, operations, and regulatory teams are aligned in their objectives and aware of audit timelines.
  • External Communication: Keep key external stakeholders, including suppliers and partners, informed about compliance expectations and any changes in the PQ process.
  • Engagement with Regulatory Authorities: Establish and maintain positive relationships with regulatory authorities such as the FDA to ensure a clear understanding of your manufacturing capabilities and compliance efforts.
Also Read:  Common WHO PQ Audit Findings in Developing Countries

Conclusion

Achieving and maintaining WHO prequalification status is a significant goal for US manufacturers aiming to enhance their global presence. By methodically following the outlined steps, organizations can prepare effectively for WHO PQ audits and significantly enhance their compliance posture. The importance of thorough documentation, strategic training, robust quality management systems, and continual improvement cannot be overstated in ensuring success in this highly regulated environment.

In summary, the key to successful WHO PQ audit readiness lies in a proactive, structured approach that emphasizes quality and compliance throughout the manufacturing process. Engaging with WHO prequalification consulting can amplify these efforts and ultimately lead to greater competitiveness and access in international markets.